WeeklyPulseNews
Money · Career · Life
Advertisement Leaderboard · 728×90
Health

India Moves to Block Adani Airport's Nicotine Pouch Challenge

The Indian government is seeking to dismiss a court challenge by an Adani Group airport over seized nicotine pouches, arguing the products are illegal and pose significant health risks to consumers.

ED
Editorial Desk
13 Jul 2026, 10:03 PM · 9 views · 4 min read
Photo by Alexander Zvir / Pexels

The Indian government has taken a firm stance against nicotine pouches, moving to quash a legal challenge filed by an airport operated by the Adani Group after authorities seized shipments of these controversial products. The case highlights growing concerns about emerging tobacco alternatives and their regulation in India.

What Are Nicotine Pouches

Nicotine pouches are small, white pouches containing nicotine but no tobacco leaf. Users place them between their gum and lip, where nicotine is absorbed through the oral mucosa. These products have gained popularity globally as an alternative to traditional tobacco products like cigarettes, gutka, and chewing tobacco.

Unlike traditional smokeless tobacco products, nicotine pouches typically contain nicotine derived from tobacco plants or synthesized, combined with flavourings, sweeteners, and plant-based fibres. They come in various flavours such as mint, citrus, and berry, which critics argue makes them appealing to younger users.

The dispute arose when customs authorities seized nicotine pouch shipments at an Adani-operated airport, citing violations of Indian import regulations. The airport operator subsequently challenged the seizure in court, arguing procedural or regulatory grounds for the import.

The government's response has been unequivocal: these products should not enter the Indian market at all. Officials argue that nicotine pouches fall under existing tobacco control regulations and their import and sale violate Indian law.

Government's Health Concerns

Indian authorities have raised several health-related objections to nicotine pouches:

  • Nicotine is a highly addictive substance that can lead to dependence, particularly concerning for young people whose brains are still developing
  • Oral health issues including gum disease, tooth decay, and mouth lesions from prolonged contact with nicotine and other chemicals
  • Cardiovascular risks as nicotine increases heart rate and blood pressure
  • Gateway effect concerns that these products might lead users, especially youth, to other tobacco products
  • Lack of long-term safety data on these relatively new products

The government has emphasized that even though nicotine pouches do not contain tobacco leaf, the nicotine itself poses significant health hazards. Public health officials worry that marketing these products as "safer alternatives" to smoking might create a false sense of security among users.

Regulatory Framework in India

India has some of the world's strictest tobacco control measures, including the Cigarettes and Other Tobacco Products Act (COTPA) 2003. However, the rapid emergence of new nicotine products has created regulatory grey areas.

The Indian government has been working to close these loopholes. Several states have already banned the sale of nicotine pouches, and there have been calls for a comprehensive national ban. The Directorate General of Health Services has issued advisories warning about the health risks of these products.

The current legal battle may set important precedent for how India regulates emerging nicotine and tobacco-alternative products. A ruling in favour of the government would strengthen the regulatory framework, while a decision favouring the importer could open doors for these products to enter the market more freely.

Global Context

India's cautious approach mirrors concerns in other countries. Several nations have restricted or banned nicotine pouches, while others have created specific regulatory frameworks. The European Union, for instance, has regulations governing nicotine pouches, while some countries have imposed outright bans.

In India, the stakes are particularly high given the country's massive population and existing burden of tobacco-related diseases. With over 267 million tobacco users, India accounts for nearly one-sixth of the world's tobacco-related deaths. Public health experts argue that preventing the establishment of new nicotine products is crucial to avoid creating another generation of addicted users.

What Happens Next

The court will need to decide whether to dismiss the airport's challenge based on the government's arguments about illegality and health risks. The outcome will have implications not just for this specific shipment but for the broader question of how India regulates nicotine products that do not fit neatly into existing tobacco product categories.

Meanwhile, health advocates are calling for clear, comprehensive legislation that explicitly covers all nicotine products regardless of whether they contain tobacco leaf, ensuring that regulatory gaps do not allow potentially harmful products to reach consumers.

This article is for general information purposes only and does not constitute legal or health advice. Readers should consult appropriate professionals for specific guidance on tobacco products, nicotine use, or related health matters.

Share
Advertisement In-article · 300×250

More from Health